SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-260686
Filing Date
2024-11-18
Accepted
2024-11-18 12:23:50
Documents
6
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 6-K d793925d6k.htm 6-K 9215
2 EX-99.1 d793925dex991.htm EX-99.1 20528
3 EX-99.2 d793925dex992.htm EX-99.2 31562
4 GRAPHIC g793925g1118175543097.jpg GRAPHIC 2601
5 GRAPHIC g793925g1118180011316.jpg GRAPHIC 2601
6 GRAPHIC g793925g99b84.jpg GRAPHIC 1277
  Complete submission text file 0001193125-24-260686.txt   71902
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241470478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)